Conference photo audience and speaker giving speech Image for Hero Box
U.S.- Israel Innovation Forum

U.S. Israel Innovation Forum

U.S.-Israel Bilateral Innovation and Best Practices Dialogue

April 27-29, 2021

The U.S. Department of Commerce in collaboration with the Economic & Trade Mission at the Embassy of Israel, the Israel Innovation Authority, and the U.S. Chamber of Commerce are hosting the second U.S.-Israel Innovation Forum, which is taking place under the Technological Innovation and Entrepreneurship Memorandum of Understanding between the Department of Commerce and the Israel Innovation Authority. 

The forum will take place on the Microsoft Teams platform and include government and private sector officials from across the United States and Israel who will address a wide array of issues ranging from collaborative models in science and technology to intellectual property rights and opportunities for collaboration in healthcare and in robotics.  

Keynote Speakers

Diane Farrell, Acting Under Secretary for International Trade, ITA/Commerce

Dr. Ami Applebaum, Chief Scientist of Israel’s Ministry of Economy and Chairman of the Israel Innovation Authority

 

U.S.-Israel Bilateral Innovation and Best Practices Dialogue

 

Best Practices in Innovation Policy and Models of Collaboration

Tuesday, April 27, 2021

9:00am-11:45am EST 
 

9:00 AM -9:15 AM

Opening Remarks (10 min)

Diane Farrell, Acting Under Secretary for International Trade, ITA/Commerce (5 min)

Dr. Ami Appelbaum, Chief Scientist of Israel’s Ministry of Economy and Chairman of the Israel Innovation Authority (5 min)

9:15 AM-10:45 AM

 

Innovation Policy Best Practices:  Intellectual Property Rights (60 minutes)

Moderators: Naomi Wiegler (Department of Commerce) and Yifat Alon Perel (Minister of Economic & Trade Affairs, Embassy of Israel)

China Intellectual Property Briefing (30 mins)

  • Elaine Wu, Principal Counsel and Director for China IP, Office of Policy and International Affairs, USPTO
  • Duncan Wilson, IP Attache, China, USPTO
  • Mike Mangleson, Principal Counsel and Director for China IP, Office of Policy and International Affairs, USPTO
     
  • IL-IP (10 min, TBC)

Patent Policy to Fostering Innovation: Patents for Humans (15 mins)

  • Soma Saha, Patent Attorney, Office of Policy and International Affairs, USPTO

10:45 AM-12:15 PM

 

Collaborative Models in Science and Technology (90 mins)

This session will focus on the broad spectrum of bilateral modes of collaboration on science and technology and present suggestions for new models/initiatives.

U.S. - Israel S&T Cooperation (10 minutes)

  • Shai-Lee Spigelman, Director General

Ministry of Science and Technology

  • Reece Smyth, Director, Office of Science and Technology Cooperation,State Department

Impactful Achievements and Highlights of the BIRD Foundation (10 minutes)

  • Dr. Eitan Yudilevich, CEO

BIRD Foundation

 

U.S. State-Driven Collaboration Initiatives (15 minutes)

  • Colorado Case: Gili Elkin

Managing Partner of Israel Colorado Innovation Fund

  • Florida Case: Tony Gannon

Vice President, Research & Innovation, Space Florida

Translating Research into Innovation- BARD-NIFA-IIA Model (10 minutes)

  • Dr. Yoram Kapulnik, CEO
  • BARD

Deploying Innovation in 3rd Countries- the IDB Case (15 minutes)

  • Yifat Alon Perel, Head of Israel Economic Mission to the United States in Washington, D.C.

Closing

The Future of Medicine:

Opportunities for Collaborative Innovation in Health Technologies 

With the U.S. Chamber of Commerce

Wednesday, April 28, 2021

8:30am – 12:00pm EST

 

8:30 AM -9:00 AM

 

The Opportunity for U.S.-Israel Health Partnership and Innovation

  • Gilad Erdan, Israel’s Ambassador to the United States*
  • Members of Congress *
  • Senior Administration Official*
  • U.S. Chamber of Commerce IL-IP (10 min, TBC)

9:00 AM-

10:00 AM

 

Exploring Partnerships in Bio-convergence

This session would focus on the newly emerging area in health contributing to major advances and progress in a range of health challenges. Look at Israel’s National Bio-convergence Initiative and understand developments in the U.S. government and private sector around bio-convergence.

  • Dr. Christopher Houchens, Director Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA)
  • DARPA*
  • MAFAT*
  • Pfizer*

Moderator: Anya Eldan, VP Startup Division and Business Development, Israel Innovation Authority

U.S. Chamber of Commerce

10:00-11:00 AM

Opportunities for Digital Health Technology in Clinical Trials

Digital (mobile) health technology offers many potential opportunities for clinical trials, including the acquisition of frequent or continuous data directly from patients wherever they are. This technology can reduce the need for in-person visits, facilitating inclusion of patients with rare diseases, patients with mobility challenges, and patients in widespread locations. Innovation in medical technology is also now able to measure patient responses to treatment in new ways for cardiorespiratory, neuromuscular, psychiatric and other diseases, as well as

 patients unable to report their symptoms. This session will explore the opportunities to measure drug efficacy in clinical trials using sensor and other technologies. The session will also address some of the challenges to the widespread implementation of mobile health and explore opportunities to continue to improve the landscape for bilateral commercial health cooperation.

  • Dr. Osnat Luxenburg, Head of the Medical Technology, Innovation, Health Information, and Research Directorate, Ministry of Health
  • Dr. Leonard Sacks, Acting Deputy Director, Office of Medical Policy, U.S. Food and Drug Administration (FDA)
  • Professor Eyal Zimlichman, Deputy Director General, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center
  • Trevor Gunn, Vice President, International Relations, Medtronic

Moderator: Esti Shelly, Head of the Digital Health Division, Ministry of Health
11:10-11:20am

Israel’s Participating in the U.S. Army Medical Technology Enterprise Consortium (MTEC)

MTEC is an international consortium with members from industry, academia and the nonprofit sector focused on accelerating the development of medical solutions that prevent and treat injuries and restore America’s military and veterans to full health

Models for U.S.-Israel Health Pilot Programs

Dr. Zvi Grunwald, CEO, Jefferson Israel Center

Opportunities for Collaborative Innovation in Robotics

Thursday, April 29, 2021

10:00am – 12:30pm EST

 

10:00-11:15 AM

 

The United States and Israel:  Landscape of Robotics Research

This session provides a high level overview on robotics research in the United States and Israel.

  • Robotics Research Capacities in Israel

Dr. Ami Ben Shalom Friedman, Senior Advisor, Israel Innovation Authority (IIA)

  • The U.S. National Robotics Initiative 3.0

Dr. Erion Plaku, Program Director, CISE/IIS, National Science Foundation

  • Measurement Science for Manufacturing Robotics Program

Dr. Craig Schlenoff, Program Manager, Measurement Science for Manufacturing Robotics Program, NIST

  • Advanced Manufacturing Programs of the Israel Innovation Authority

Dr. Malka Nir, Head of Advanced Manufacturing Division, Israel Innovation Authority (IIA)

  • Priority Areas in Robotics R&D

Arnie Kravitz, Chief Technology Officer, Advanced Robotics for Manufacturing Institute (ARM)

11:15 AM-12:15 PM

 

 

 

Applications for Robotics in Manufacturing

This session addresses the exchange of ideas on the use of robotics in manufacturing and defense applications.

  • Smart Collaborative Robots for Manufacturing Applications (20 mins)

Dr. Satyandra K. Gupta, Smith International Professor in the Department of Aerospace and Mechanical Engineering and Department of Computer Science, Viterbi School of Engineering  University of Southern California (confirmed)

  • Robotics in Aeronautics                                                                 

Dr. Ofer Lapid, Senior Advisor, Israel Innovation Authority (IIA)

  • Human-Robot Interaction, Prof. Tal Oron, Ben Gurion University

Moderator:  Dr. Jeremy Marvel, Intelligent Systems Division, NIST

 

×

Global Business Navigator Chatbot Beta

Welcome to the Global Business Navigator, an artificial intelligence (AI) Chatbot from the International Trade Administration (ITA). This tool, currently in beta version testing, is designed to provide general information on the exporting process and the resources available to assist new and experienced U.S. exporters. The Chatbot, developed using Microsoft’s Azure AI services, is trained on ITA’s export-related content and aims to quickly get users the information they need. The Chatbot is intended to make the benefits of exporting more accessible by understanding non-expert language, idiomatic expressions, and foreign languages.

Limitations

As a beta product, the Chatbot is currently being tested and its responses may occasionally produce inaccurate or incomplete information. The Chatbot is trained to decline out of scope or inappropriate requests. The Chatbot’s knowledge is limited to the public information on the Export Solutions web pages of Trade.gov, which covers a wide range of topics on exporting. While it cannot provide responses specific to a company’s product or a specific foreign market, its reference pages will guide you to other relevant government resources and market research. Always double-check the Chatbot’s responses using the provided references or by visiting the Export Solutions web pages on Trade.gov. Do not use its responses as legal or professional advice. Inaccurate advice from the Chatbot would not be a defense to violating any export rules or regulations.

Privacy

The Chatbot does not collect information about users and does not use the contents of users’ chat history to learn new information. All feedback is anonymous. Please do not enter personally identifiable information (PII), sensitive, or proprietary information into the Chatbot. Your conversations will not be connected to other interactions or accounts with ITA. Conversations with the Chatbot may be reviewed to help ITA improve the tool and address harmful, illegal, or otherwise inappropriate questions.

Translation

The Chatbot supports a wide range of languages. Because the Chatbot is trained in English and responses are translated, you should verify the translation. For example, the Chatbot may have difficulty with acronyms, abbreviations, and nuances in a language other than English.

Privacy Program | Information Quality Guidelines | Accessibility